MIL-OSI: Update on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder foreignaffairs.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from foreignaffairs.co.nz Daily Mail and Mail on Sunday newspapers.
Axsome Therapeutics (NASDAQ:AXSM – Free Report) had its target price raised by HC Wainwright from $180.00 to $190.00 in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Axsome Therapeutics’ Q2 2024 earnings at ($1.08) EPS, Q3 […]
Truist Financial restated their buy rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report issued on Tuesday, Benzinga reports. The brokerage currently has a $150.00 price target on the stock. AXSM has been the topic of a number of other reports. Cantor Fitzgerald reaffirmed an overweight rating and set a $108.00 […]
Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $127 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Analysts Set Axsome Therapeutics, Inc (NASDAQ:AXSM) Price Target at $115 36 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.